英格兰2000-2010年肾癌肾切除术服务供给与生存趋势
结果显示肾切除术数量增加66%,医院数量减少24%而医院年手术量中位数从10增至23,微创手术占比从1%升至46%,保留肾单位手术从5%升至16%。30天死亡率从2.4%降至1.1%,1年相对生存率从86.9%升至93.4%,5年相对生存率从68.2%升至81.2%。
要点
- 肾切除术向大型医院集中,医院年手术量中位数从10增至23。
- 微创手术占比从1%升至46%,保留肾单位手术从5%升至16%。
- 30天死亡率从2.4%降至1.1%,5年相对生存率从68.2%升至81.2%。
核心结论
- 肾癌手术治疗模式发生显著变化,表现为肾切除术集中化、保留肾单位手术和微创手术增加。
- 短期和长期生存率均显著改善,老年患者和局部晚期患者获益最明显。
主要发现
- 肾切除术年数量增加66%,医院数量减少24%,医院年手术量中位数从10增至23(P < 0.01)。
- 外科医生数量增加27%(P < 0.01),每院顾问医师中位数翻倍。
- 微创手术占比从1%升至46%,保留肾单位手术从5%升至16%,2010年29%的T1期患者接受部分肾切除术(P < 0.01)。
- 30天死亡率从2.4%降至1.1%,90天死亡率从4.9%降至2.6%(P < 0.01)。
- 1年相对生存率从86.9%升至93.4%,5年相对生存率从68.2%升至81.2%(P < 0.01)。
临床怎么用
- 肾癌肾切除术应向高手术量医院集中,以改善短期和长期生存结局。
- 在适用患者中应提高微创手术和保留肾单位手术的应用比例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the temporal trends in nephrectomy practice and outcomes for English patients with renal cell carcinoma (RCC). PATIENTS AND METHODS: Adult RCC nephrectomy patients treated between 2000 and 2010 were identified in the National Cancer Data Repository and Hospital Episode Statistics, and followed-up until date of death or 31 December 2015 (n = 30 763). We estimated the annual frequency for each nephrectomy type, the hospital and surgeon numbers and their case volumes. We analysed short-term surgical outcomes, as well as 1- and 5-year relative survivals. RESULTS: Annual RCC nephrectomy number increased by 66% during the study period. Hospital number decreased by 24%, whilst the median annual hospital volume increased from 10 to 23 (P < 0.01). Surgeon number increased by 27% (P < 0.01), doubling the median consultant number per hospital. The proportion of minimally invasive surgery (MIS) nephrectomies rose from 1% to 46%, whilst the proportion of nephron-sparing surgeries (NSS) increased from 5% to 16%, with 29% of all T1 disease treated with partial nephrectomy in 2010 (P < 0.01). The 30-day mortality rate halved from 2.4% to 1.1% and 90-day mortality decreased from 4.9% to 2.6% (P < 0.01). The 1-year relative survival rate increased from 86.9% to 93.4%, whilst the 5-year relative survival rate rose from 68.2% to 81.2% (P < 0.01). Improvements were most notable in patients aged ≥65 years and those with T3 and T4 disease. CONCLUSIONS: Surgical RCC management has changed considerably with nephrectomy centralisation and increased NSS and MIS. In parallel, we observed significant improvements in short- and long-term survival particularly for elderly patients and those with locally advanced disease.
引用
- Hsu RCJ, Barclay M, Loughran MA, et al. Time trends in service provision and survival outcomes for patients with renal cancer treated by nephrectomy in England 2000-2010. BJU Int. 2018. PMID: 29603575. doi:10.1111/bju.14217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。